Firms
Theme

JMSB

John Marshall Bancorp, Inc. · NASDAQ

News

3 latest

Zacks Investment Research

John Marshall Bancorp, Inc. (JMSB) Earnings Expected to Grow: Should You Buy?

John Marshall Bancorp (JMSB) is expected to report Q3 2026 earnings of $0.50 per share, representing a 31.6% year-over-year increase, with revenues projected at $18.56 million (up 14.2%). However, despite a positive Earnings ESP of +2.00%, the stock carries a Zacks Rank #5 (Strong Sell), making it difficult to predict an earnings beat. The company has beaten consensus estimates in 2 of the last 4 quarters.

Mentions JMSB

Zacks Investment Research

First Citizens BancShares (FCNCA) Surpasses Q3 Earnings and Revenue Estimates

First Citizens BancShares reported Q3 2026 earnings of $55.37 per share, beating consensus estimates of $46.61 by 18.79%, and revenues of $2.27 billion, surpassing estimates by 1.86%. The company has beaten EPS estimates in all four of the last quarters.

Zacks Investment Research

WesBanco (WSBC) Q3 Earnings Surpass Estimates

WesBanco (WSBC) reported Q3 2026 earnings of $0.89 per share, beating consensus estimates of $0.87, but missed revenue expectations at $272.74 million versus the estimate of $276.32 million. The stock has outperformed the S&P 500 by 50 basis points year-to-date. Despite the earnings beat, the company maintains a Zacks Rank #3 (Hold) rating due to mixed estimate revision trends, suggesting near-term performance in line with the market.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $JMSB · 0 threads

Sign in to post on $JMSB

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev